Echo Research and Practice最新文献

{"title":"A practical guideline for performing a comprehensive transthoracic echocardiogram in the congenital heart disease patient: consensus recommendations from the British Society of Echocardiography.","authors":"Liam Corbett,&nbsp;Jan Forster,&nbsp;Wendy Gamlin,&nbsp;Nuno Duarte,&nbsp;Owen Burgess,&nbsp;Allan Harkness,&nbsp;Wei Li,&nbsp;John Simpson,&nbsp;Radwa Bedair","doi":"10.1186/s44156-022-00006-5","DOIUrl":"https://doi.org/10.1186/s44156-022-00006-5","url":null,"abstract":"<p><p>Transthoracic echocardiography is an essential tool in the diagnosis, assessment, and management of paediatric and adult populations with suspected or confirmed congenital heart disease. Congenital echocardiography is highly operator-dependent, requiring advanced technical acquisition and interpretative skill levels. This document is designed to complement previous congenital echocardiography literature by providing detailed practical echocardiography imaging guidance on sequential segmental analysis, and is intended for implementation predominantly, but not exclusively, within adult congenital heart disease settings. It encompasses the recommended dataset to be performed and is structured in the preferred order for a complete anatomical and functional sequential segmental congenital echocardiogram. It is recommended that this level of study be performed at least once on all patients being assessed by a specialist congenital cardiology service. This document will be supplemented by a series of practical pathology specific congenital echocardiography guidelines. Collectively, these will provide structure and standardisation to image acquisition and reporting, to ensure that all important information is collected and interpreted appropriately.</p>","PeriodicalId":45749,"journal":{"name":"Echo Research and Practice","volume":" ","pages":"10"},"PeriodicalIF":6.3,"publicationDate":"2022-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578224/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40395385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Feasibility, diagnostic performance and clinical value of an abbreviated echocardiography protocol in an out-patient cardiovascular setting: a pilot study.","authors":"Sher May Ng,&nbsp;Danial Naqvi,&nbsp;Jose Bingcang,&nbsp;Gemma Cruz,&nbsp;Richard Nose,&nbsp;Guy Lloyd,&nbsp;Marie Elsya Speechly-Dick,&nbsp;Sanjeev Bhattacharyya","doi":"10.1186/s44156-022-00009-2","DOIUrl":"https://doi.org/10.1186/s44156-022-00009-2","url":null,"abstract":"<p><strong>Background: </strong>There has been a growing demand for echocardiography services over the last 5 years, with this supply-demand mismatch exacerbated by the COVID-19 pandemic. Prior studies have suggested a high proportion of normal findings among echocardiograms requested for patients without known cardiovascular disease, particularly in low-risk cohorts. This pilot study investigates the role of an abbreviated echocardiography protocol in improving access to echocardiography services in a low-risk outpatient setting within the rapid access chest pain (RACP) clinic.</p><p><strong>Method: </strong>A retrospective review of electronic medical records and transthoracic echocardiography (TTE) studies for 212 patients from RACP clinic in 2019 (cohort A), prior to the introduction of the abbreviated echocardiography protocol, and 175 patients seen in the RACP clinic in 2021 (cohort B) was performed. The outcomes measured include the echocardiography referral burden from RACP clinic, waiting time for a TTE and echocardiography findings.</p><p><strong>Results: </strong>33% and 45% of patients seen in the RACP clinic in 2019 and 2021, respectively, were referred for a TTE. The most common indications include chest pain (50%), dyspnoea (19%) and palpitations (11%). Abnormal findings were identified in 36% of TTEs performed in cohort A and 13% in cohort B. The median echocardiogram study time was significantly shorter in cohort B (7 min vs 13 min, p < 0.00001), with a lower number of images acquired (43 vs. 62, p < 0.00001). The median waiting time for an echocardiography in cohort B was significantly shorter (median: 14 days vs. 42 days in 2019, p < 0.00001). No major pathologies were missed on a retrospective review of these images.</p><p><strong>Conclusion: </strong>Our study demonstrates that an abbreviated echocardiography protocol has potential to improve access to echocardiography services through increasing scheduling capacity, without compromising diagnostic performance in a low-risk outpatient population.</p>","PeriodicalId":45749,"journal":{"name":"Echo Research and Practice","volume":" ","pages":"8"},"PeriodicalIF":6.3,"publicationDate":"2022-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473732/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40357608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"CEUS cardiac exam protocols International Contrast Ultrasound Society (ICUS) recommendations.","authors":"Thomas R Porter,&nbsp;Steven B Feinstein,&nbsp;Roxy Senior,&nbsp;Sharon L Mulvagh,&nbsp;Petros Nihoyannopoulos,&nbsp;Jordan B Strom,&nbsp;Wilson Mathias,&nbsp;Beverly Gorman,&nbsp;Arnaldo Rabischoffsky,&nbsp;Michael L Main,&nbsp;Andrew Appis","doi":"10.1186/s44156-022-00008-3","DOIUrl":"https://doi.org/10.1186/s44156-022-00008-3","url":null,"abstract":"<p><p>The present CEUS Cardiac Exam Protocols represent the first effort to promulgate a standard set of protocols for optimal administration of ultrasound enhancing agents (UEAs) in echocardiography, based on more than two decades of experience in the use of UEAs for cardiac imaging. The protocols reflect current clinical CEUS practice in many modern echocardiography laboratories throughout the world. Specific attention is given to preparation and dosing of three UEAs that have been approved by the United States Food and Drug Administration (FDA) and additional regulatory bodies in Europe, the Americas and Asia-Pacific. Consistent with professional society guidelines (J Am Soc Echocardiogr 31:241-274, 2018; J Am Soc Echocardiogr 27:797-810, 2014; Eur Heart J Cardiovasc Imaging 18:1205, 2017), these protocols cover unapproved \"off-label\" uses of UEAs-including stress echocardiography and myocardial perfusion imaging-in addition to approved uses. Accordingly, these protocols may differ from information provided in product labels, which are generally based on studies performed prior to product approval and may not always reflect state of the art clinical practice or guidelines.</p>","PeriodicalId":45749,"journal":{"name":"Echo Research and Practice","volume":" ","pages":"7"},"PeriodicalIF":6.3,"publicationDate":"2022-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396906/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40411562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Echo Research and Practice enters a new era.","authors":"Mark Monaghan","doi":"10.1186/s44156-022-00007-4","DOIUrl":"https://doi.org/10.1186/s44156-022-00007-4","url":null,"abstract":"","PeriodicalId":45749,"journal":{"name":"Echo Research and Practice","volume":" ","pages":"6"},"PeriodicalIF":6.3,"publicationDate":"2022-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277952/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40609853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical indications and triaging for adult transthoracic echocardiography: a consensus statement by the British Society of Echocardiography in collaboration with British Heart Valve Society.","authors":"Sadie Bennett, Martin Stout, Thomas E Ingram, Keith Pearce, Timothy Griffiths, Simon Duckett, Grant Heatlie, Patrick Thompson, Judith Tweedie, Jo Sopala, Sarah Ritzmann, Kelly Victor, Judith Skipper, Shaun Robinson, Andrew Potter, Daniel X Augustine, Claire L Colebourn","doi":"10.1186/s44156-022-00003-8","DOIUrl":"10.1186/s44156-022-00003-8","url":null,"abstract":"<p><p>Transthoracic echocardiography (TTE) is widely utilised within many aspects of clinical practice, as such the demand placed on echocardiography services is ever increasing. In an attempt to provide incremental value for patients and standardise patient care, the British Society of Echocardiography in collaboration with the British Heart Valve Society have devised updated guidance for the indications and triaging of adult TTE requests for TTE services to implement into clinical practice.</p>","PeriodicalId":45749,"journal":{"name":"Echo Research and Practice","volume":"9 1","pages":"5"},"PeriodicalIF":3.2,"publicationDate":"2022-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277869/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9078545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Echocardiographic description and outcomes in a heterogeneous cohort of patients undergoing mitral valve surgery with and without mitral annular disjunction: a health service evaluation.","authors":"Sadie Bennett,&nbsp;Jacopo Tafuro,&nbsp;Marcus Brumpton,&nbsp;Caragh Bardolia,&nbsp;Grant Heatlie,&nbsp;Simon Duckett,&nbsp;Paul Ridley,&nbsp;Prakash Nanjaiah,&nbsp;Chun Shing Kwok","doi":"10.1186/s44156-022-00004-7","DOIUrl":"https://doi.org/10.1186/s44156-022-00004-7","url":null,"abstract":"<p><strong>Background: </strong>Mitral annular disjunction (MAD) is a structural abnormality characterized by the distinct separation of the mitral valve annulus/left atrium wall and myocardium. Little is known about the significance of MAD in patients requiring mitral valve surgery. This evaluation evaluates the echocardiographic characteristics and patient outcomes for patients with and without MAD who require mitral valve surgery.</p><p><strong>Methods: </strong>All patients who underwent mitral valve surgery and who had a pre-surgical transthoracic echocardiogram between 2013 and 2020 were included. Patient demographics and clinical outcomes were collected on review of patient electronic records.</p><p><strong>Results: </strong>A total of 185 patients were included in the analysis of which 32.4% had MAD (average MAD length 8.4 mm). MAD was seen most commonly in patients with mitral valve prolapse and myxomatous mitral valves disease (90% and 60% respectively). In the patients with MAD prior to mitral valve surgery, only 3.9% had MAD post mitral valve surgery. There were no significant difference in the severity of post-operative mitral regurgitation, arrhythmic events or major adverse cardiovascular events in patients with and without MAD.</p><p><strong>Conclusions: </strong>MAD is common in patients who undergo mitral valve surgery. Current surgical techniques are able to correct the MAD abnormality in the vast majority of patients. MAD is not associated with an increased risk of adverse clinical outcomes post mitral valve surgery.</p>","PeriodicalId":45749,"journal":{"name":"Echo Research and Practice","volume":" ","pages":"4"},"PeriodicalIF":6.3,"publicationDate":"2022-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277900/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40609874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The 35th annual advances in contrast ultrasound international bubble conference, Chicago 2021: synopsis and take-home messages","authors":"Michael Dunleavy, Alan B Goldberg, S. Feinstein, Stephanie Wilson, S. Mulvagh, P. Nihoyannopoulos","doi":"10.1186/s44156-022-00002-9","DOIUrl":"https://doi.org/10.1186/s44156-022-00002-9","url":null,"abstract":"","PeriodicalId":45749,"journal":{"name":"Echo Research and Practice","volume":" ","pages":""},"PeriodicalIF":6.3,"publicationDate":"2022-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48542242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The assessment of mitral valve disease: a guideline from the British Society of Echocardiography.","authors":"Shaun Robinson,&nbsp;Liam Ring,&nbsp;Daniel X Augustine,&nbsp;Sushma Rekhraj,&nbsp;David Oxborough,&nbsp;Allan Harkness,&nbsp;Patrizio Lancellotti,&nbsp;Bushra Rana","doi":"10.1530/ERP-20-0034","DOIUrl":"https://doi.org/10.1530/ERP-20-0034","url":null,"abstract":"<p><p>Mitral valve disease is common. Mitral regurgitation is the second most frequent indication for valve surgery in Europe and despite the decline of rheumatic fever in Western societies, mitral stenosis of any aetiology is a regular finding in all echo departments. Mitral valve disease is, therefore, one of the most common pathologies encountered by echocardiographers, as both a primary indication for echocardiography and a secondary finding when investigating other cardiovascular disease processes. Transthoracic, transoesophageal and exercise stress echocardiography play a crucial role in the assessment of mitral valve disease and are essential to identifying the aetiology, mechanism and severity of disease, and for helping to determine the appropriate timing and method of intervention. This guideline from the British Society of Echocardiography (BSE) describes the assessment of mitral regurgitation and mitral stenosis, and replaces previous BSE guidelines that describe the echocardiographic assessment of mitral anatomy prior to mitral valve repair surgery and percutaneous mitral valvuloplasty. It provides a comprehensive description of the imaging techniques (and their limitations) employed in the assessment of mitral valve disease. It describes a step-wise approach to identifying: aetiology and mechanism, disease severity, reparability and secondary effects on chamber geometry, function and pressures. Advanced echocardiographic techniques are described for both transthoracic and transoesophageal modalities, including TOE and exercise testing.</p>","PeriodicalId":45749,"journal":{"name":"Echo Research and Practice","volume":"8 1","pages":"G87-G136"},"PeriodicalIF":6.3,"publicationDate":"2021-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cb/7e/ERP-20-0034.PMC8495880.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39054913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transthoracic echocardiography of hypertrophic cardiomyopathy in adults: a practical guideline from the British Society of Echocardiography.","authors":"Lauren Turvey,&nbsp;Daniel X Augustine,&nbsp;Shaun Robinson,&nbsp;David Oxborough,&nbsp;Martin Stout,&nbsp;Nicola Smith,&nbsp;Allan Harkness,&nbsp;Lynne Williams,&nbsp;Richard P Steeds,&nbsp;William Bradlow","doi":"10.1530/ERP-20-0042","DOIUrl":"https://doi.org/10.1530/ERP-20-0042","url":null,"abstract":"<p><p>Hypertrophic cardiomyopathy (HCM) is common, inherited and characterised by unexplained thickening of the myocardium. The British Society of Echocardiography (BSE) has recently published a minimum dataset for transthoracic echocardiography detailing the core views needed for a standard echocardiogram. For patients with confirmed or suspected HCM, additional views and measurements are necessary. This guideline, therefore, supplements the minimum dataset and describes a tailored, stepwise approach to the echocardiographic examination, and echocardiography's position in the diagnostic pathway, before advising on the imaging of disease complications and invasive treatments.</p>","PeriodicalId":45749,"journal":{"name":"Echo Research and Practice","volume":"8 1","pages":"G61-G86"},"PeriodicalIF":6.3,"publicationDate":"2021-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4b/07/ERP-20-0042.PMC8243716.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25433242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The role of the Tei index in assessing for cardiotoxicity from anthracycline chemotherapy: a systematic review.","authors":"Sadie Bennett,&nbsp;Arzu Cubukcu,&nbsp;Chun Wai Wong,&nbsp;Timothy Griffith,&nbsp;Cheryl Oxley,&nbsp;Diane Barker,&nbsp;Simon Duckett,&nbsp;Duwarakan Satchithananda,&nbsp;Ashish Patwala,&nbsp;Grant Heatlie,&nbsp;Chun Shing Kwok","doi":"10.1530/ERP-20-0013","DOIUrl":"https://doi.org/10.1530/ERP-20-0013","url":null,"abstract":"<p><strong>Background: </strong>Anthracycline agents are known to be effective in treating tumors and hematological malignancies. Although these agents improve survival, their use is associated with cardiotoxic effects, which most commonly manifests as left ventricular systolic dysfunction (LVSD). As such, guidelines recommend the periodic assessment of left ventricular ejection fraction (LVEF). However, as diastolic dysfunction likely proceeds systolic impairment in this setting, the role of Tei index may offer additional benefit in detecting subclinical LVSD.</p><p><strong>Methods: </strong>We conducted a systematic review to investigate the evidence for the use of Tei index in assessing subclinical cardiotoxicity in patients receiving anticancer agents. A search of Medline and EMBASE was performed and relevant studies were reviewed and narratively synthesized.</p><p><strong>Results: </strong>A total of 13 studies were included with a total of 800 patients (mean age range 46-62 years, percentage of male participants ranged from 0-86.9%). An increase in Tei index was observed in 11 studies, which suggested a decline in cardiac function following chemotherapy. Out of these, six studies indicated that the Tei index is a useful parameter in predicting cardiotoxic LVSD. Furthermore, five studies indicated Tei index to be superior to LVEF in detecting subclinical cardiotoxicity.</p><p><strong>Conclusions: </strong>Though there are some studies that suggest that Tei index may be a useful indicator in assessing subclinical anthracycline-related cardiotoxicity, the findings are inconsistent and so more studies are needed before the evaluation of Tei index is performed routinely in patients receiving chemotherapy.</p>","PeriodicalId":45749,"journal":{"name":"Echo Research and Practice","volume":"8 1","pages":"R1-R11"},"PeriodicalIF":6.3,"publicationDate":"2021-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/98/15/ERP-20-0013.PMC8185452.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25539169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}